Teva Pharmaceutical Industries Ltd. — Earnings Release 2014

Feb 5, 2015

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD7217Corporation no: 520013954Stock Exchange/Market: NYSE310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: tomer.amitai@teva.co.ilReported via MAGNA: 05/02/2015              Time of broadcast: 14:01 14:00:53

Reference: 2015-02-026065

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Teva reports fourth quarter and full year 2014 results
Q4-14_PR_HEBREW_-_FINAL_isa.pdf

Includes non-binding Hebrew translation
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 12/01/2015
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 03-9267736 , Facsimile: 03-9148678 , E-mail: osnat.ram@teva.co.il 2